Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Rangering i aksjer #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Aksjekurs
$11.03
Sist synkronisert: 2026-08-28
Markedsverdi
$597.15M
Endring (1 dag)
-4.25%
Endring (1 år)
-
Land
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Kategori

Historikk for aksjesplitt for Eikon Therapeutics, Inc. Common Stock (EIKN)
Aksjen Eikon Therapeutics, Inc. Common Stock (symbol: EIKN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 31, 2026.
Én EIKN-aksje kjøpt før Aug 31, 2026 tilsvarer i dag 0 EIKN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH